Troy Ignelzi is a finance, operations, and business development executive with extensive experience in developing financing strategies and executing mergers and acquisitions. Currently serving as the Chief Financial Officer at Rapport Therapeutics and as a board member for several companies including Abivax and Contineum Therapeutics, Troy has been instrumental in raising capital for significant clinical developments and successful IPOs. Previously, they held key roles such as Chief Financial Officer at Juventas Therapeutics and scPharmaceuticals, and Vice President at Insys Therapeutics and Esperion Therapeutics, where they secured substantial funding to support clinical trials and operational initiatives. Troy’s educational background includes studies in Accounting, Finance, and Business Administration from institutions like Ferris State University and Western Michigan University.
This person is not in any offices